Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma.
Mo J, Zaremba A, Inderjeeth AJ, El Zeinaty P, Li A, Wicky A, Della Marta N, Marqueste CG, Bohne AS, Matias M, McNamee N, Festino L, Chen C, Ch'ng S, van Akkooi ACJ, Meda LD, Park JJ, Ascierto PA, Hauschild A, Lee JH, Grob JJ, Mangana J, Guminski A, Michielin O, Xu W, Lebbe C, Sandhu S, Zimmer L, Menzies AM, Lo SN, Long GV, Carlino MS, da Silva IP.
Mo J, et al. Among authors: park jj.
Eur J Cancer. 2025 Jan 27;217:115254. doi: 10.1016/j.ejca.2025.115254. Online ahead of print.
Eur J Cancer. 2025.
PMID: 39874912